Biopharmaceutical, COVID-19

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded $8.9 million for high-impact biopharmaceutical manufacturing projects to support the nation’s response to the COVID-19 pandemic. Authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act signed by President Donald Trump in March...

Additive Manufacturing, Biopharmaceutical, Digital Manufacturing, Education, Flexible Hybrid Electronics, Photonics, Process Intensification, Recycling, Robotics, Workforce

The Advanced Robotics for Manufacturing (ARM) Institute, through a partnership with its fellow Manufacturing USA® Institutes and led by Nextflex®, has been awarded funding from the Office of Naval Research for new manufacturing workforce education activities. The ARM Institute has partnered with Pittsburgh-based members, New Century Careers and...

Biopharmaceutical

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, is pleased to announce funding for 14 new projects in technology, workforce development, and in their Global Health Fund initiative, resulting from the Institute’s Project Call 3.1, and with a total value of approximately $10M.

“New...

Biopharmaceutical, COVID-19

The last few weeks have undoubtedly been a paradigm shift for many in our community. Whether an educator, parent, student, scientist, or executive - every single member of the NIIMBL community is adapting quickly to new norms in our business, academic, and personal lives in response to the current coronavirus pandemic. As the world is waiting for...

Biomanufacturing, Biopharmaceutical

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative Research and Development Agreement (CRADA) with the Food and Drug Administration (FDA). Effective July 15, 2019, the FDA and NIIMBL will...